upadacitinib hemihydrate · Medicine question

What does the product information state about pharmaceutical incompatibilities for Rinvoq 15 mg prolonged-release tablets?

Name: What does the product information state about pharmaceutical incompatibilities for Rinvoq 15 mg prolonged-release tablets?
Published: 2026-11-08T14:30:15.570Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

The product information for Rinvoq 15 mg prolonged-release tablets states that pharmaceutical incompatibilities are “Not applicable.”

Sources for this answer

RINVOQ 15 mg prolonged-release tabletsAbbVie Ltd · emc · SmPC §6.2 Incompatibilities · Version 28Document updated 22 June 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about upadacitinib hemihydrate